# Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial)

Study · id `cardio:ct-nct07349888` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07349888](<https://clinicaltrials.gov/study/NCT07349888>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07349888

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 404 participants.

## Technical summary

Registry record NCT07349888. Randomized; single masking; primary purpose treatment. Start 2026-02-01 (anticipated); primary completion 2031-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 404 participants (planned count; ClinicalTrials.gov record NCT07349888, source copy `cardio:ctgov-nct07349888-2026-01-20`, retrieved 2026-10-26)
- Planned start: 2026-02-01 (anticipated) (ClinicalTrials.gov record NCT07349888, source copy `cardio:ctgov-nct07349888-2026-01-20`, retrieved 2026-10-26)
- Primary completion: 2031-02-28 (anticipated) (ClinicalTrials.gov record NCT07349888, source copy `cardio:ctgov-nct07349888-2026-01-20`, retrieved 2026-10-26)
- Completion: 2031-08-31 (anticipated) (ClinicalTrials.gov record NCT07349888, source copy `cardio:ctgov-nct07349888-2026-01-20`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07349888-2026-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial)
- Condition: Mitral Regurgitation
- Condition: Tricuspid Regurgitation
- Intervention (Device): Transcatheter Edge-to-Edge Repair (TEER) System
- Lead sponsor: Nanjing First Hospital, Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Nanjing First Hospital, Nanjing Medical University (`cardio:org-nanjing-first-hospital-nanjing-medical-university`)

## Provenance

Content hash: a6242171cb0dc45803ad99959f571b89dde8843c83231687c6072d51431bb988
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
